Big Pharma Split Corp Class A (PRM)
Toronto Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 15.01 |
|---|---|
| 52-week range | 11.91 – 16.10 |
| Return, 1 month / 3 months | +4.7% / +8.8% |
| Return, 1 year / 3 years | +35.3% / +38.2% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 0.02M CAD |
| Dividend yield | 8.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Big Pharma Split Corp Class A (PRM) trades on the Toronto Exchange in Canada. It last closed at CAD 15.01 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 196 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.3% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.2% | ||
| From 52-week high | -6.2% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 12.9% | ||
| 12-month return, skipping the last month | 29.2% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CAD | ||
| Zero-volume days | 25.0% | ||
| Income | 79 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | +4.7% |
| 3 months | +8.8% |
| 6 months | +12.9% |
| 1 year | +35.3% |
| 3 years | +38.2% |
| 5 years | +74.9% |
Signals
| 50-day / 200-day average | 14.80 / 13.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.1030 |
| 31 Aug 2026 | CAD 0.1030 |
| 31 Jul 2026 | CAD 0.1030 |
| 30 Jun 2026 | CAD 0.1030 |
| 29 May 2026 | CAD 0.1030 |
| 30 Apr 2026 | CAD 0.1030 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.